Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP632165.RAdUUB9Whwv9mwh4fKV4ROKtatN4muafh8x2TM-sO0RdI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP632165.RAdUUB9Whwv9mwh4fKV4ROKtatN4muafh8x2TM-sO0RdI130_assertion type Assertion NP632165.RAdUUB9Whwv9mwh4fKV4ROKtatN4muafh8x2TM-sO0RdI130_head.
- NP632165.RAdUUB9Whwv9mwh4fKV4ROKtatN4muafh8x2TM-sO0RdI130_assertion description "[These results show for the first time that TGF-beta2, its receptors TGF-beta R1 and TGF-beta R2, and activator thrombospondin-1 are concordantly suppressed early in breast carcinogenesis by histone modifications and indicate that the TGF-beta signaling pathway is a novel target for gene activation by epigenetic therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP632165.RAdUUB9Whwv9mwh4fKV4ROKtatN4muafh8x2TM-sO0RdI130_provenance.
- NP632165.RAdUUB9Whwv9mwh4fKV4ROKtatN4muafh8x2TM-sO0RdI130_assertion evidence source_evidence_literature NP632165.RAdUUB9Whwv9mwh4fKV4ROKtatN4muafh8x2TM-sO0RdI130_provenance.
- NP632165.RAdUUB9Whwv9mwh4fKV4ROKtatN4muafh8x2TM-sO0RdI130_assertion SIO_000772 18089780 NP632165.RAdUUB9Whwv9mwh4fKV4ROKtatN4muafh8x2TM-sO0RdI130_provenance.
- NP632165.RAdUUB9Whwv9mwh4fKV4ROKtatN4muafh8x2TM-sO0RdI130_assertion wasDerivedFrom befree-20140225 NP632165.RAdUUB9Whwv9mwh4fKV4ROKtatN4muafh8x2TM-sO0RdI130_provenance.
- NP632165.RAdUUB9Whwv9mwh4fKV4ROKtatN4muafh8x2TM-sO0RdI130_assertion wasGeneratedBy ECO_0000203 NP632165.RAdUUB9Whwv9mwh4fKV4ROKtatN4muafh8x2TM-sO0RdI130_provenance.